Lifyorli Kit
RxNorm Crosswalk NDC 76346-550

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Lifyorli (NDC 76346-550) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 16 unique RxNorm concepts. By anchoring Corcept Therapeutics Incorporated's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCDPrescribable
Featured Concept

relacorilant 100 MG Oral Capsule
(RxCUI 2739542)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Lifyorli 100 MG Oral Capsule
(RxCUI 2739548)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

relacorilant 25 MG Oral Capsule
(RxCUI 2739550)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Lifyorli 25 MG Oral Capsule
(RxCUI 2739552)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

relacorilant 125 MG, 1-Dose Pack
(RxCUI 2739553)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Lifyorli 125 MG, 1-Dose Pack
(RxCUI 2739554)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

relacorilant 150 MG, 1-Dose Pack
(RxCUI 2739555)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Lifyorli 150 MG, 1-Dose Pack
(RxCUI 2739556)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

relacorilant 125 MG, 3-Dose Pack
(RxCUI 2739557)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Lifyorli 125 MG, 3-Dose Pack
(RxCUI 2739558)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

relacorilant 125 MG, 9-Dose Pack
(RxCUI 2739559)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Lifyorli 125 MG, 9-Dose Pack
(RxCUI 2739560)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

relacorilant 150 MG, 3-Dose Pack
(RxCUI 2739561)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Lifyorli 150 MG, 3-Dose Pack
(RxCUI 2739562)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

relacorilant 150 MG, 9-Dose Pack
(RxCUI 2739563)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

Lifyorli 150 MG, 9-Dose Pack
(RxCUI 2739564)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Understanding RxNorm Mapping for Lifyorli

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 76346-550 to RxCUI 2739542, 2739548, 2739550, 2739552, 2739553, 2739554, 2739555, 2739556, 2739557, 2739558, 2739559, 2739560, 2739561, 2739562, 2739563, 2739564, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
  • GPCK Generic Pack: A standardized concept for a clinical kit containing multiple generic components.
  • BPCK Branded Pack: A standardized concept for a clinical kit containing multiple branded components.

* Please review the full disclaimer at the bottom of this page.